Yu CJ - Search Results

1

Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6.

Yang JC, Sequist LV, Geater SL, Tsai CM, Mok TS, Schuler M, Yamamoto N, Yu CJ, Ou SH, Zhou C, Massey D, Zazulina V, Wu YL. Yang JC, et al. Among authors: yu cj. Lancet Oncol. 2015 Jul;16(7):830-8. doi: 10.1016/S1470-2045(15)00026-1. Epub 2015 Jun 4. Lancet Oncol. 2015. PMID: 26051236 Clinical Trial.

2

Exon 8 mutation of p53 gene associated with nodal metastasis in non-small-cell lung cancer.

Lee LN, Shew JY, Sheu JC, Lee YC, Lee WC, Fang MT, Chang HF, Yu CJ, Yang PC, Luh KT. Lee LN, et al. Among authors: yu cj. Am J Respir Crit Care Med. 1994 Dec;150(6 Pt 1):1667-71. doi: 10.1164/ajrccm.150.6.7952630. Am J Respir Crit Care Med. 1994. PMID: 7952630

3

Mucin mRNA expression in lung adenocarcinoma cell lines and tissues.

Yu CJ, Yang PC, Shew JY, Hong TM, Yang SC, Lee YC, Lee LN, Luh KT, Wu CW. Yu CJ, et al. Oncology. 1996 Mar-Apr;53(2):118-26. doi: 10.1159/000227547. Oncology. 1996. PMID: 8604237

4

High dose tamoxifen plus cisplatin and etoposide in the treatment of patients with advanced, inoperable nonsmall cell lung carcinoma.

Yang CH, Cheng AL, Yeh KH, Yu CJ, Lin JF, Yang PC. Yang CH, et al. Among authors: yu cj. Cancer. 1999 Aug 1;86(3):415-20. doi: 10.1002/(sici)1097-0142(19990801)86:3<415::aid-cncr9>3.0.co;2-h. Cancer. 1999. PMID: 10430249 Clinical Trial.

5

Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer.

Yuan A, Yu CJ, Kuo SH, Chen WJ, Lin FY, Luh KT, Yang PC, Lee YC. Yuan A, et al. Among authors: yu cj. J Clin Oncol. 2001 Jan 15;19(2):432-41. doi: 10.1200/JCO.2001.19.2.432. J Clin Oncol. 2001. PMID: 11208836

6

Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer.

Yuan A, Yu CJ, Luh KT, Kuo SH, Lee YC, Yang PC. Yuan A, et al. Among authors: yu cj. J Clin Oncol. 2002 Feb 15;20(4):900-10. doi: 10.1200/JCO.2002.20.4.900. J Clin Oncol. 2002. PMID: 11844810

7

Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials.

Kuo SH, Yang CH, Yu CJ, Hsu C, Cheng AL, Yang PC. Kuo SH, et al. Among authors: yu cj. Lung Cancer. 2005 May;48(2):275-80. doi: 10.1016/j.lungcan.2004.10.004. Epub 2004 Dec 15. Lung Cancer. 2005. PMID: 15829329

8

Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma.

Chen KY, Chang CH, Yu CJ, Kuo SH, Yang PC. Chen KY, et al. Among authors: yu cj. Cancer. 2005 Jun 15;103(12):2566-74. doi: 10.1002/cncr.21087. Cancer. 2005. PMID: 15852359 Free article.

9

Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer.

Shih JY, Gow CH, Yu CJ, Yang CH, Chang YL, Tsai MF, Hsu YC, Chen KY, Su WP, Yang PC. Shih JY, et al. Among authors: yu cj. Int J Cancer. 2006 Feb 15;118(4):963-9. doi: 10.1002/ijc.21458. Int J Cancer. 2006. PMID: 16152581

10

Gefitinib treatment for non-small cell lung cancer -- a study including patients with poor performance status.

Su WP, Yang CH, Yu CJ, Shih JY, Hsu C, Yang PC. Su WP, et al. Among authors: yu cj. J Formos Med Assoc. 2005 Aug;104(8):557-62. J Formos Med Assoc. 2005. PMID: 16193176

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,045 results

Search Page

Filters